In an era of increasingly bespoke healthcare, Elizabeth Philp has become a significant figure of innovation, notably in the technologically advancing field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a movement to make bespoke medications more obtainable, challenging the conventional o